A Study of Abatacept in Patients With Active Ulcerative Colitis

NCT00410410 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

591

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: abatacept (ABA)
DRUG: placebo
DRUG: abatacept

Sponsor

Bristol-Myers Squibb